Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

Biotechnology Reagents & Kits Market Growth is Driven by Advancements in Molecular Biology, Personalized Medicine, and Automation; North America and Asia-Pacific Lead Regional Expansion.Austin, United ...

Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China ...

Scientists have long been trying to tease apart hepatitis A virus, to understand its inner workings and how it functions in the human body. Infectious disease researchers have discovered that a little ...

The "Cutaneous T-cell lymphoma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive insights about 25+ companies and 30+ ...

These therapies are designed to combat antibody-producing cells ... s unbiased sequencing approach accurately identifies ...

New research has illustrated how hepatitis A virus uses cellular proteins, like PDAP1, to infect liver cells, replicate and ...

Viruses have thrived in humans for tens of thousands of years, evolving to take advantage of the machinery of cells to ...

Recall that scientists developed CRISPR-Cas9 based on a unique mechanism in ... We are using biological therapies such as protein vaccines, antibodies, and enzymes to treat a variety of diseases ...

The deal focuses on the development of degrader-antibody conjugates (DACs), a fairly ... which became the first based on the CRISPR/Cas9 gene-editing technology to be approved towards the end ...